Articoli di riviste sul tema "Daunorubicin"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Daunorubicin".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Drevin, Guillaume, Marie Briet, Caroline Bazzoli, et al. "Daunorubicin and Its Active Metabolite Pharmacokinetic Profiles in Acute Myeloid Leukaemia Patients: A Pharmacokinetic Ancillary Study of the BIG-1 Trial." Pharmaceutics 14, no. 4 (2022): 792. http://dx.doi.org/10.3390/pharmaceutics14040792.
Testo completoZucchetti, Massimo, Amerigo Boiardi, Antonio Silvani, Idria Parisi, Stefano Piccolrovazzi, and Maurizio D'Incalci. "Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin." Cancer Chemotherapy and Pharmacology 44, no. 2 (1999): 173–76. http://dx.doi.org/10.1007/s002800050964.
Testo completo&NA;. "Daunorubicin see Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 354 (1991): 8. http://dx.doi.org/10.2165/00128415-199103540-00027.
Testo completoChoi, Min-Koo, Im-Sook Song, Dae-Duk Kim, Suk-Jae Chung, and Chang-Koo Shim. "Altered Pharmacokinetics of Daunorubicin in Rats with CCl4-Induced Hepatic Injury." Journal of Pharmacy & Pharmaceutical Sciences 10, no. 4 (2007): 443. http://dx.doi.org/10.18433/j3mw28.
Testo completoCusack, B. J., Stephan P. Young, Robert E. Vestal, and Richard D. Olson. "Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat." Cancer Chemotherapy and Pharmacology 39, no. 6 (1997): 505–12. http://dx.doi.org/10.1007/s002800050606.
Testo completoNikanjam, Mina, Edmund Capparelli, Jeffrey E. Lancet, Jonathan E. Kolitz, Arthur C. Louie, and Gary J. Schiller. "Enhanced Cytarabine and Daunorubicin Population Pharmacokinetics When Administered As CPX-351: A Novel Liposomal Formulation Not Requiring Dose Reduction for Mild Renal or Hepatic Dysfunction." Blood 128, no. 22 (2016): 3955. http://dx.doi.org/10.1182/blood.v128.22.3955.3955.
Testo completoAlves, Ana Catarina, Daniela Ribeiro, Miguel Horta, José L. F. C. Lima, Cláudia Nunes, and Salette Reis. "A biophysical approach to daunorubicin interaction with model membranes: relevance for the drug's biological activity." Journal of The Royal Society Interface 14, no. 133 (2017): 20170408. http://dx.doi.org/10.1098/rsif.2017.0408.
Testo completoAlbrecht, K. W., S. Leenstra, P. J. M. Bakker, et al. "High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin." Clinical Neurology and Neurosurgery 99 (July 1997): S231. http://dx.doi.org/10.1016/s0303-8467(97)82346-3.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1184 (2008): 15. http://dx.doi.org/10.2165/00128415-200811840-00044.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 562 (1995): 6. http://dx.doi.org/10.2165/00128415-199505620-00017.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 392 (1992): 5. http://dx.doi.org/10.2165/00128415-199203920-00013.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 398 (1992): 6. http://dx.doi.org/10.2165/00128415-199203980-00014.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 407 (1992): 5. http://dx.doi.org/10.2165/00128415-199204070-00010.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 898 (2002): 6. http://dx.doi.org/10.2165/00128415-200208980-00016.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1263 (2009): 15. http://dx.doi.org/10.2165/00128415-200912630-00046.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1243 (2009): 18–19. http://dx.doi.org/10.2165/00128415-200912430-00055.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1257 (2009): 17–18. http://dx.doi.org/10.2165/00128415-200912570-00053.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 338 (1991): 4. http://dx.doi.org/10.2165/00128415-199103380-00018.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 357 (1991): 6. http://dx.doi.org/10.2165/00128415-199103570-00024.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1297 (2010): 21. http://dx.doi.org/10.2165/00128415-201012970-00062.
Testo completo&NA;. "Daunorubicin." Reactions Weekly &NA;, no. 1333 (2011): 19. http://dx.doi.org/10.2165/00128415-201113330-00057.
Testo completoHempel, Georg, Petra Schulze-Westhoff, Silke Flege, and Joachim Boos. "Quantification of daunorubicin and daunorubicinol in plasma by capillary electrophoresis." Journal of Chromatography B: Biomedical Sciences and Applications 758, no. 2 (2001): 221–28. http://dx.doi.org/10.1016/s0378-4347(01)00185-2.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1395 (2012): 17–18. http://dx.doi.org/10.2165/00128415-201213950-00056.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1397 (2012): 14. http://dx.doi.org/10.2165/00128415-201213970-00046.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 751 (1999): 7. http://dx.doi.org/10.2165/00128415-199907510-00019.
Testo completo&NA;. "Daunorubicin/mitoxantrone." Reactions Weekly &NA;, no. 1158 (2007): 12. http://dx.doi.org/10.2165/00128415-200711580-00029.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1363 (2011): 16. http://dx.doi.org/10.2165/00128415-201113630-00058.
Testo completo&NA;. "Daunorubicin/pirarubicin." Reactions Weekly &NA;, no. 1366 (2011): 13. http://dx.doi.org/10.2165/00128415-201113660-00044.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1371 (2011): 14. http://dx.doi.org/10.2165/00128415-201113710-00049.
Testo completo&NA;. "Doxorubicin/daunorubicin." Reactions Weekly &NA;, no. 439 (1993): 8. http://dx.doi.org/10.2165/00128415-199304390-00040.
Testo completo&NA;. "Doxorubicin/daunorubicin." Reactions Weekly &NA;, no. 471 (1993): 8. http://dx.doi.org/10.2165/00128415-199304710-00036.
Testo completo&NA;. "Daunorubicin liposomal." Reactions Weekly &NA;, no. 814 (2000): 6–7. http://dx.doi.org/10.2165/00128415-200008140-00011.
Testo completo&NA;. "Daunorubicin liposomal." Reactions Weekly &NA;, no. 829 (2000): 7. http://dx.doi.org/10.2165/00128415-200008290-00018.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1399 (2012): 12–13. http://dx.doi.org/10.2165/00128415-201213990-00040.
Testo completo&NA;. "Daunorubicin/doxorubicin." Reactions Weekly &NA;, no. 373 (1991): 5. http://dx.doi.org/10.2165/00128415-199103730-00023.
Testo completo&NA;. "Daunorubicin/doxorubicin." Reactions Weekly &NA;, no. 423 (1992): 7. http://dx.doi.org/10.2165/00128415-199204230-00026.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1213 (2008): 16. http://dx.doi.org/10.2165/00128415-200812130-00046.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1106 (2006): 10. http://dx.doi.org/10.2165/00128415-200611060-00029.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 898 (2002): 6. http://dx.doi.org/10.2165/00128415-200208980-00015.
Testo completo&NA;. "Cyclophosphamide/daunorubicin." Reactions Weekly &NA;, no. 1258 (2009): 13. http://dx.doi.org/10.2165/00128415-200912580-00043.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1280 (2009): 18–19. http://dx.doi.org/10.2165/00128415-200912800-00057.
Testo completo&NA;. "Daunorubicin/doxorubicin." Reactions Weekly &NA;, no. 1252 (2009): 19. http://dx.doi.org/10.2165/00128415-200912520-00064.
Testo completo&NA;. "Daunorubicin/doxorubicin." Reactions Weekly &NA;, no. 292 (1990): 5. http://dx.doi.org/10.2165/00128415-199002920-00014.
Testo completo&NA;. "Daunorubicin/doxorubicin." Reactions Weekly &NA;, no. 348 (1991): 7. http://dx.doi.org/10.2165/00128415-199103480-00027.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 354 (1991): 8. http://dx.doi.org/10.2165/00128415-199103540-00026.
Testo completo&NA;. "Daunorubicin/mitoxantrone." Reactions Weekly &NA;, no. 1309 (2010): 18. http://dx.doi.org/10.2165/00128415-201013090-00054.
Testo completo&NA;. "Daunorubicin/idarubicin." Reactions Weekly &NA;, no. 946 (2003): 8–9. http://dx.doi.org/10.2165/00128415-200309460-00024.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1291 (2010): 17. http://dx.doi.org/10.2165/00128415-201012910-00050.
Testo completo&NA;. "Cytarabine/daunorubicin." Reactions Weekly &NA;, no. 1294 (2010): 16. http://dx.doi.org/10.2165/00128415-201012940-00047.
Testo completo&NA;. "Daunorubicin/tretinoin." Reactions Weekly &NA;, no. 1301 (2010): 18. http://dx.doi.org/10.2165/00128415-201013010-00064.
Testo completo